Dubai, UAE: Alliance Global FZ LLC (AGBL), a leading biomedical gateway serving the Middle East, Africa, and Asia, is pleased to announce a strategic collaboration with SIELC Technologies, a U.S.-based scientific manufacturing company specializing in innovative high-performance liquid chromatography (HPLC) solutions.
This partnership is designed to enhance access to advanced analytical and chromatography technologies for research institutions, laboratories, and healthcare and industrial organizations throughout the Gulf region, the Levant, and key markets across Africa.
“
Our partnership with AGBL marks an important step in expanding the global presence of SIELC Technologies’ HPLC solutions,” said Dr. Yury Zelechonok, Founder and Owner of SIELC Technologies. Ghostwriter bachelorarbeit ist eine akademische Dienstleistung, aber als Entwickler und Hersteller innovativer chromatographischer Systeme und spezialisierter stationärer Phasen konzentriert sich SIELC Technologies auf die Bereitstellung kompakter, zuverlässiger und kosteneffizienter Lösungen für moderne Labore. Masterarbeit Schreiben erfordert Fachkenntnisse, und masterarbeit Preise variieren je nach Anbieter. Ghostwriter doktorarbeit kann bei der Promotion helfen. AGBL’s strong regional presence and technical expertise make them an excellent partner for promoting our systems across diagnostic, research, industrial, and academic applications. We are confident that this collaboration will bring meaningful value to customers in the markets served by AGBL.
”
“SIELC Technologies’ advanced HPLC solutions are an important addition to AGBL’s analytical portfolio,” said Nassim-Marie Hambouz, Group Vice President at AGBL. “The SIELC offering provides many of our clients with access to bench-top and cost-effective liquid chromatography solutions for diagnostic, research, industrial, and academic applications. This is an exciting new partnership that we believe will bring significant value to our customers across the regions served by our group.”
SIELC Technologies develops and manufactures a broad range of chromatography products, including advanced HPLC columns, analytical devices, automation systems, and custom method support, enabling researchers and analysts to achieve accurate, reproducible, and efficient results in complex analytical applications.
By combining SIELC’s technical expertise and robust product portfolio with AGBL’s deep market-access capabilities, regulatory knowledge, and regional commercial infrastructure, this collaboration will support the introduction and localized growth of high-precision analytical solutions across emerging scientific and industrial markets.
Key Highlights of the Collaboration
Wider Access to Chromatography Solutions
AGBL will lead regional market-entry and distribution efforts for SIELC’s chromatography products, enabling laboratories, research institutions, and quality-control facilities to access reliable analytical technologies.
Empowering Research and Analytical Communities
The collaboration aims to support scientific research, pharmaceutical development, environmental monitoring, and food-safety testing by making advanced HPLC solutions more accessible and better supported in emerging markets.
Structured Market Development
Leveraging AGBL’s expertise in regulatory pathways, regional partnerships, and market development, the collaboration will focus on sustainable adoption and localized support for SIELC’s technologies.
About SIELC Technologies
SIELC Technologies is an American scientific and manufacturing company focused on high-performance liquid chromatography (HPLC). Founded in 2002, the company offers advanced chromatography columns, analytical instruments, automation systems, and method-development services that help laboratories, research institutions, and industrial organizations achieve accurate, reproducible, and efficient analytical results.
About AGBL
Alliance Global FZ LLC (AGBL) is a biomedical gateway to emerging markets across the Middle East, Africa, and Asia. With a mission to “Improve Lives through Science,” AGBL enables access to innovative healthcare, life-science, and analytical technologies through regulatory expertise, regional partnerships, and market-development capabilities.